| Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test V Almeida, R Levin, FF Peres, ST Niigaki, MB Calzavara, AW Zuardi, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 41, 30-35, 2013 | 111 | 2013 |
| Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats FF Peres, R Levin, MA Suiama, MC Diana, DA Gouvêa, V Almeida, ... Frontiers in pharmacology 7, 343, 2016 | 76 | 2016 |
| Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain R Levin, FF Peres, V Almeida, MB Calzavara, AW Zuardi, JEC Hallak, ... Frontiers in pharmacology 5, 10, 2014 | 76 | 2014 |
| Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats MB Calzavara, R Levin, WA Medrano, V Almeida, APF Sampaio, ... Behavioural brain research 225 (1), 15-22, 2011 | 66 | 2011 |
| Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia FF Peres, MC Diana, R Levin, MA Suiama, V Almeida, AM Vendramini, ... Frontiers in pharmacology 9, 2018 | 59 | 2018 |
| Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain V Almeida, FF Peres, R Levin, MA Suiama, MB Calzavara, AW Zuardi, ... Schizophrenia research 153 (1-3), 150-159, 2014 | 58 | 2014 |
| Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia R Levin, V Almeida, F Fiel Peres, M Bendlin Calzavara, N Derci da Silva, ... Current pharmaceutical design 18 (32), 4960-4965, 2012 | 55 | 2012 |
| Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia FF Peres, MC Diana, MA Suiama, V Justi, V Almeida, RA Bressan, ... Schizophrenia research 172 (1), 220-221, 2016 | 34 | 2016 |
| Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy FF Peres, R Levin, V Almeida, AW Zuardi, JE Hallak, JA Crippa, VC Abilio Frontiers in Pharmacology 7, 303, 2016 | 26 | 2016 |
| Changes in the blood plasma lipidome associated with effective or poor response to atypical antipsychotic treatments in schizophrenia patients V de Almeida, GL Alexandrino, A Aquino, AF Gomes, M Murgu, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 101, 109945, 2020 | 24 | 2020 |
| Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit V Almeida, R Levin, FF Peres, MA Suiama, AM Vendramini, CM Santos, ... Neuropharmacology, 2019 | 22 | 2019 |
| Biochemical pathways triggered by antipsychotics in human oligodendrocytes: Potential of discovering new treatment targets C Brandão-Teles, VR De Almeida, JS Cassoli, D Martins-de-Souza Frontiers in pharmacology 10, 186, 2019 | 21 | 2019 |
| Cannabinoids and glial cells: possible mechanism to understand schizophrenia V de Almeida, D Martins-de-Souza European archives of psychiatry and clinical neuroscience 268, 727-737, 2018 | 21 | 2018 |
| Young spontaneously hypertensive rats (SHRs) display prodromal schizophrenia-like behavioral abnormalities ST Niigaki, FF Peres, L Ferreira, T Libanio, DA Gouvea, R Levin, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2018 | 20 | 2018 |
| Ubiquitin–proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia G Seabra, V de Almeida, G Reis-de-Oliveira, F Crunfli, ASLM Antunes, ... Scientific reports 10 (1), 12655, 2020 | 19 | 2020 |
| Digging deeper in the proteome of different regions from schizophrenia brains G Reis-de-Oliveira, GS Zuccoli, M Fioramonte, A Schimitt, P Falkai, ... Journal of proteomics 223, 103814, 2020 | 17 | 2020 |
| Proteomic markers for depression LC Silva-Costa, PT Carlson, PC Guest, V de Almeida, ... Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders …, 2019 | 12 | 2019 |
| Proteomics and lipidomics in the elucidation of endocannabinoid signaling in healthy and schizophrenia brains G Seabra, ACB Falvella, PC Guest, D Martins‐de‐Souza, V de Almeida Proteomics 18 (18), 1700270, 2018 | 10 | 2018 |
| The multimodal Munich Clinical Deep Phenotyping study to bridge the translational gap in severe mental illness treatment research L Krčmář, I Jäger, E Boudriot, K Hanken, V Gabriel, J Melcher, N Klimas, ... Frontiers in Psychiatry 14, 1179811, 2023 | 7 | 2023 |
| Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Front Pharmacol 2018; 9: 901 FF Peres, MC Diana, R Levin, MA Suiama, V Almeida, AM Vendramini | 7 | 2018 |
